The patent, issued in 2009, is for a compound that Merck’s Idenix unit contends is the basis for all major treatments for hepatitis C. Read more
Gilead Sciences Inc. has halted six clinical trials involving the cancer drug Zydelig. Read more
The U.S. Securities and Exchange Commission has charged five Florida residents, including two lawyers, in a New Jersey federal court with allegations of insider trading related to Gilead Sci... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.